CellFACE awarded SMART Innovation Grant 2.0

22.09.2025

 

We are proud to share that CellFACE has been awarded the Singapore-MIT Alliance for Research & Technology (SMART) Innovation Grant 2.0 to advance and commercialise our AI-powered, real-time phase imaging flow cytometry.

CellFACE delivers point-of-care results of activated leukocytes and cell aggregates in just 1.5 minutes, matching the needs for acute care, such as in the operating theatre.

Click here to watch the Revolutionise Acute Care with CellFACE video

With the support of the SMART Innovation Grant 2.0, we are moving forward into business development and clinical validation, bringing real-time, label-free diagnostics from the bench to the bedside.

Recently, on 28 August 2025, the CellFACE team wrapped up their research project with a closing event that brought both Munich and Singapore clinicians together.

The session featured a deep dive into the scientific findings and how the technology created at CREATE differs from other imaging flow cytometry systems for the point-of-care. The workflow processes big amounts of data and generates clinical value for infection diagnostics in critical time windows. 

Physicians and engineers also provided insights about the future of hematology, and PD Dr Martin Schlegel from the Technical University of Munich gave a keynote on sepsis diagnostics.

A big thank you to all attendees for joining us and for the lively round-table discussion on the clinical unmet needs.